Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

PURPOSE: To report the outcomes of half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). METHODS: A chart review of patients with chronic CSC who had received half-dose verteporfin PDT (3 mg/m(2)) was performed. The main outcome measures were resolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseripour, Masood, Falavarjani, Khalil Ghasemi, Sedaghat, Ahad, Moghaddam, Arezoo Karimi, Nasserisina, Sadaf, Alemzadeh, Sayyed Amirpooya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860990/
https://www.ncbi.nlm.nih.gov/pubmed/27195088
http://dx.doi.org/10.4103/2008-322X.180706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860990/
https://www.ncbi.nlm.nih.gov/pubmed/27195088
http://dx.doi.org/10.4103/2008-322X.180706

Ejemplares similares